✦ LIBER ✦

A Pilot Study of Leukocytapheresis Efficacy With 1.5 Liter Blood Processing Volume in Patients With Ulcerative Colitis

✍ Scribed by Masaaki Shimada; Hiroaki Iwase; Tomoyuki Tsuzuki; Noboru Hirashima; Kyoko Kobayashi; Yusuke Hibino; Hisanori Watanabe; Nobumitsu Ryuge; Takafumi Ando; Hidemi Goto; Yuhki Yagi; Tomoyuki Tsujikawa; Akira Andoh

Book ID: 111334074
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 175 KB
Volume: 12
Category: Article
ISSN: 1091-6660
DOI: 10.1111/j.1744-9987.2008.00611.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S2018 The Processed Blood Volume Per Leu

S2018 The Processed Blood Volume Per Leukocytapheresis Session in Patients With Ulcerative Colitis

✍ Kamikozuru, Koji; Fukunaga, Ken; Yokoyama, Yoko; Miwa, Hiroto; Matsumoto, Takayu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Optimal apheresis treatment volume for t

Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with cellsorba in patients with active ulcerative colitis

✍ Ken Fukunaga; Koji Kamikozuru; Yoko Yokoyama; Nobuyuki Hida; Yoshio Ohda; Naohis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract **Background**: Leukocytapheresis (LCAP) is used as an adjunct therapy for patients with active ulcerative colitis (UC). Although, LCAP is routinely performed at 3,000 mL per session, we were interested to see that if this can be replaced with bodyweight (BW) adjusted volume. **Methods*

Processed blood volume impacts clinical

Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytes

✍ Naoki Yoshimura; Tokuma Tadami; Takaaki Kawaguchi; Minako Sako; Hiroshi Yoshimot 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 292 KB

W1234 A Prospective Follow-Up Study to A

W1234 A Prospective Follow-Up Study to Assess the Long-Term Efficacy of Leukocytapheresis in Patients with Steroid Refractory Ulcerative Colitis

✍ Fukunaga, Ken; Ohnishi, Kunio; Hida, Nobuyuki; Ohda, Yoshio; Tozawa, Katsuyuki; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 103 KB

A multicenter study of the efficacy and

A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis

✍ Toshifumi Ashida; Yutaka Kohgo; Akihiro Munakata; Mitsunori Noguchi; Bunei Iizuk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Mucosal healing in patients with ulcerat

Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: A prospective cohort study

✍ Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Background: During active ulcerative colitis (UC), vast numbers of granulocytes, monocytes/macrophages (GM) infiltrate the mucosal tissue and can potentially exacerbate inflammation and injury. Accordingly, we were interested to see if selective depletion of GM by adsorption (GMA) impacts mucosal he